Etoposide phosphate and Insulin Aspart Protamine Injection
Determining the interaction of Etoposide phosphate and Insulin Aspart Protamine Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: etoposide
Brand name: VePesid, Etopophos, Toposar
Synonyms: Etoposide
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Etoposide phosphate-Insulin aspart, recombinant Subcutaneous
- Etoposide phosphate-Insulin degludec
- Etoposide phosphate-Insulin Degludec (U-100) Prefilled Pens
- Etoposide phosphate-Insulin Degludec (U-100) Vials
- Etoposide phosphate-Insulin Degludec (U-200) Prefilled Pens
- Etoposide phosphate-Insulin degludec and liraglutide
- Insulin Aspart Protamine Injection-Etrafon
- Insulin Aspart Protamine Injection-Etrafon Forte
- Insulin Aspart Protamine Injection-Etravirine
- Insulin Aspart Protamine Injection-Eucalyptamint
- Insulin Aspart Protamine Injection-Eudermis Wound Care
- Insulin Aspart Protamine Injection-Euflexxa